Robert T Foster Hepion Pharmaceuticals, Inc. (HEPA) insider trading activity

HEPA Quotes by TradingView

Robert T Foster is CEO and Director of Hepion Pharmaceuticals, Inc.. Currently has a direct ownership of 50,470 shares of HEPA, which is worth approximately $25,235. The most recent transaction as insider was on Sep 18, 2023, when has been sold 1,600 shares (Common Stock) at a price of $5.6 per share, resulting in proceeds of $8,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.5K
0% 3M change
0% 12M change
Total Value Held $25,235

Robert T Foster Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2023
BUY
Open market or private purchase
$8,960 $5.6 p/Share
1,600 Added 3.07%
50,470 Common Stock
Sep 15 2023
BUY
Open market or private purchase
$8,640 $5.4 p/Share
1,600 Added 3.17%
48,870 Common Stock
Feb 18 2021
BUY
Open market or private purchase
$40,000 $2.0 p/Share
20,000 Added 30.65%
45,259 Common Stock
Dec 08 2020
BUY
Open market or private purchase
$39,500 $1.58 p/Share
25,000 Added 49.74%
25,259 Common Stock

Also insider at

AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
RTF

Robert T Foster

CEO and Director
Edison, NJ

Track Institutional and Insider Activities on HEPA

Follow Hepion Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HEPA shares.

Notify only if

Insider Trading

Get notified when an Hepion Pharmaceuticals, Inc. insider buys or sells HEPA shares.

Notify only if

News

Receive news related to Hepion Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HEPA